In the present study, SQS overexpression increased OPN, pSrc, pERK1/2 and pAKT473 levels in lung cancer cells, whereas knockdown of SQS or treatment with SKI significantly reduced the levels of pSrc and pERK1/2 (Fig. 4a–c). The gene discussed is SPP1; the disease is lung carcinoma.